Triamcinolone acetonide remaining on the fovea after successful macular hole closure.
Fukukita
Mitsushi
M
Department of Ophthalmology, Mie University School of Medicine, Tsu Mie, Japan.
Sasoh
Mikio
M
Matsubara
Hisashi
H
Furuta
Motoyasu
M
Okawa
Chikahiro
C
Ito
Yoshikazu
Y
Wakitani
Yoshikatsu
Y
Uji
Yukitaka
Y
D005260:Female; D005584:Fovea Centralis / Q000187:drug effects*; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D012167:Retinal Perforations / Q000473:pathology / Q000601:surgery*; D013459:Sulfur Hexafluoride / Q000008:administration & dosage; D041623:Tomography, Optical Coherence; D014222:Triamcinolone Acetonide / Q000009:adverse effects* / Q000627:therapeutic use; D014821:Vitrectomy
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide; D013459:Sulfur Hexafluoride